These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Regulation of IRF-3-dependent innate immunity by the papain-like protease domain of the severe acute respiratory syndrome coronavirus. Devaraj SG; Wang N; Chen Z; Chen Z; Tseng M; Barretto N; Lin R; Peters CJ; Tseng CT; Baker SC; Li K J Biol Chem; 2007 Nov; 282(44):32208-21. PubMed ID: 17761676 [TBL] [Abstract][Full Text] [Related]
5. The Conserved Coronavirus Macrodomain Promotes Virulence and Suppresses the Innate Immune Response during Severe Acute Respiratory Syndrome Coronavirus Infection. Fehr AR; Channappanavar R; Jankevicius G; Fett C; Zhao J; Athmer J; Meyerholz DK; Ahel I; Perlman S mBio; 2016 Dec; 7(6):. PubMed ID: 27965448 [TBL] [Abstract][Full Text] [Related]
6. SARS-coronavirus open reading frame-9b suppresses innate immunity by targeting mitochondria and the MAVS/TRAF3/TRAF6 signalosome. Shi CS; Qi HY; Boularan C; Huang NN; Abu-Asab M; Shelhamer JH; Kehrl JH J Immunol; 2014 Sep; 193(6):3080-9. PubMed ID: 25135833 [TBL] [Abstract][Full Text] [Related]
7. SARS coronavirus and innate immunity. Frieman M; Heise M; Baric R Virus Res; 2008 Apr; 133(1):101-12. PubMed ID: 17451827 [TBL] [Abstract][Full Text] [Related]
8. Innate Immune Responses to Highly Pathogenic Coronaviruses and Other Significant Respiratory Viral Infections. Ahmed-Hassan H; Sisson B; Shukla RK; Wijewantha Y; Funderburg NT; Li Z; Hayes D; Demberg T; Liyanage NPM Front Immunol; 2020; 11():1979. PubMed ID: 32973803 [TBL] [Abstract][Full Text] [Related]
9. Heterologous viral RNA export elements improve expression of severe acute respiratory syndrome (SARS) coronavirus spike protein and protective efficacy of DNA vaccines against SARS. Callendret B; Lorin V; Charneau P; Marianneau P; Contamin H; Betton JM; van der Werf S; Escriou N Virology; 2007 Jul; 363(2):288-302. PubMed ID: 17331558 [TBL] [Abstract][Full Text] [Related]
10. Virus-specific memory CD8 T cells provide substantial protection from lethal severe acute respiratory syndrome coronavirus infection. Channappanavar R; Fett C; Zhao J; Meyerholz DK; Perlman S J Virol; 2014 Oct; 88(19):11034-44. PubMed ID: 25056892 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2-associated ssRNAs activate inflammation and immunity via TLR7/8. Salvi V; Nguyen HO; Sozio F; Schioppa T; Gaudenzi C; Laffranchi M; Scapini P; Passari M; Barbazza I; Tiberio L; Tamassia N; Garlanda C; Del Prete A; Cassatella MA; Mantovani A; Sozzani S; Bosisio D JCI Insight; 2021 Sep; 6(18):. PubMed ID: 34375313 [TBL] [Abstract][Full Text] [Related]
13. Mouse-passaged severe acute respiratory syndrome-associated coronavirus leads to lethal pulmonary edema and diffuse alveolar damage in adult but not young mice. Nagata N; Iwata N; Hasegawa H; Fukushi S; Harashima A; Sato Y; Saijo M; Taguchi F; Morikawa S; Sata T Am J Pathol; 2008 Jun; 172(6):1625-37. PubMed ID: 18467696 [TBL] [Abstract][Full Text] [Related]
14. Inosine-mediated modulation of RNA sensing by Toll-like receptor 7 (TLR7) and TLR8. Sarvestani ST; Tate MD; Moffat JM; Jacobi AM; Behlke MA; Miller AR; Beckham SA; McCoy CE; Chen W; Mintern JD; O'Keeffe M; John M; Williams BR; Gantier MP J Virol; 2014 Jan; 88(2):799-810. PubMed ID: 24227841 [TBL] [Abstract][Full Text] [Related]
15. Distinct SARS-CoV-2 RNA fragments activate Toll-like receptors 7 and 8 and induce cytokine release from human macrophages and microglia. Wallach T; Raden M; Hinkelmann L; Brehm M; Rabsch D; Weidling H; Krüger C; Kettenmann H; Backofen R; Lehnardt S Front Immunol; 2022; 13():1066456. PubMed ID: 36713399 [TBL] [Abstract][Full Text] [Related]
16. Severe acute respiratory syndrome-associated coronavirus vaccines formulated with delta inulin adjuvants provide enhanced protection while ameliorating lung eosinophilic immunopathology. Honda-Okubo Y; Barnard D; Ong CH; Peng BH; Tseng CT; Petrovsky N J Virol; 2015 Mar; 89(6):2995-3007. PubMed ID: 25520500 [TBL] [Abstract][Full Text] [Related]
17. Exacerbated innate host response to SARS-CoV in aged non-human primates. Smits SL; de Lang A; van den Brand JM; Leijten LM; van IJcken WF; Eijkemans MJ; van Amerongen G; Kuiken T; Andeweg AC; Osterhaus AD; Haagmans BL PLoS Pathog; 2010 Feb; 6(2):e1000756. PubMed ID: 20140198 [TBL] [Abstract][Full Text] [Related]
18. [Potent neutralization antibody elicited in mice by SARS-associated coronavirus spike protein S1 domain]. Zhang Y; Yang F; Li YH; Li WH; Tu XM; Wei Q; Zhu H; Liu L; Wang H; Qin C; Yuan GY; He W; Wang SH Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2004 Sep; 18(3):258-60. PubMed ID: 15640862 [TBL] [Abstract][Full Text] [Related]
19. Severe acute respiratory syndrome coronaviruses with mutations in the E protein are attenuated and promising vaccine candidates. Regla-Nava JA; Nieto-Torres JL; Jimenez-Guardeño JM; Fernandez-Delgado R; Fett C; Castaño-Rodríguez C; Perlman S; Enjuanes L; DeDiego ML J Virol; 2015 Apr; 89(7):3870-87. PubMed ID: 25609816 [TBL] [Abstract][Full Text] [Related]
20. Severe acute respiratory syndrome and the innate immune responses: modulation of effector cell function without productive infection. Tseng CT; Perrone LA; Zhu H; Makino S; Peters CJ J Immunol; 2005 Jun; 174(12):7977-85. PubMed ID: 15944304 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]